Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-09-30

FDA Approved: PATADAY TWICE A DAY RELIEF — Supplemental Application (Alcon Laboratories, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Pataday Twice a Day Relief (olopatadine hydrochloride) by Alcon Laboratories, expanding labeling related to its …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PATADAY TWICE A DAY RELIEF (olopatadine hydrochloride)

Snippet

SUPPL AP for PATADAY TWICE A DAY RELIEF (OLOPATADINE HYDROCHLORIDE)